Fibroblast growth factor receptor 3 kinase domain mutation increases cortical progenitor proliferation via mitogen-activated protein kinase activation

Journal of Neurochemistry

Volumn 100, Issue 6, 2007, Pages 1565-1578

  Thomson, Rachel E ^a   Pellicano, Francesca ^a   Iwata, Tomoko ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cell proliferation; Cerebral cortex; Development; Fibroblast growth factor receptor 3; Mitogen activated protein kinase; Neuroepithelium

Indexed keywords

BROXURIDINE; FIBROBLAST GROWTH FACTOR RECEPTOR 3; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; SPROUTY PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; CELL PROLIFERATION; CHEMICAL LABELING; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME INHIBITION; FEEDBACK SYSTEM; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUTATION; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; WILD TYPE;

AGE FACTORS; ANIMALS; BROMODEOXYURIDINE; CELL PROLIFERATION; CELLS, CULTURED; CEREBRAL CORTEX; EMBRYO; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IN SITU HYBRIDIZATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; PREGNANCY; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS;

MUS;

EID: 33847740369     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04285.x     Document Type: Article

References (64)

1. Bellus G. A., Bamshad M. J., Przylepa K. A. et al. (1999) Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3. Am. J. Med. Genet. 85, 53-65.
2. Brader S. and Eccles S. A. (2004) Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis. Tumori 90, 2-8.
3. Caviness V. S. Jr, Takahashi T. and Nowakowski R. S. (1995) Numbers, time and neocortical neuronogenesis: a general developmental and evolutionary model. Trends Neurosci. 18, 379-383.
4. Colvin J. S., Bohne B. A., Harding G.W., McEwen D. G. and Ornitz D. M. (1996) Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet. 12, 390-397.
5. Corson L. B., Yamanaka Y., Lai K. M. and Rossant J. (2003) Spatial and temporal patterns of ERK signaling during mouse embryogenesis. Development 130, 4527-4537.
6. Crossley P. H. and Martin G. R. (1995) The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development 121, 439-451.
7. Crossley P. H., Martinez S., Ohkubo Y. and Rubenstein J. L. (2001) Coordinate expression of Fgf8, Otx2, Bmp4, and Shh in the rostral prosencephalon during development of the telencephalic and optic vesicles. Neuroscience 108, 183-206.
8. Dailey L., Ambrosetti D., Mansukhani A. and Basilico C. (2005) Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev. 16, 233-247.
9. Deng C., Wynshaw-Boris A., Zhou F., Kuo A. and Leder P. (1996) Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84, 911-921.
10. Dono R., Texido G., Dussel R., Ehmke H. and Zeller R. (1998) Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO J. 17, 4213-4225.
11. Echevarria D., Vieira C., Gimeno L. and Martinez S. (2003) Neuroepithelial secondary organizers and cell fate specification in the developing brain. Brain Res. Brain Res. Rev. 43, 179-191.
12. Eswarakumar V. P., Lax I. and Schlessinger J. (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16, 139-149.
13. Fong C. W., Leong H. F., Wong E. S., Lim J., Yusoff P. and Guy G. R. (2003) Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function. J. Biol. Chem. 278, 33 456-33 464.
14. Ford-Perriss M., Abud H. and Murphy M. (2001) Fibroblast growth factors in the developing central nervous system. Clin. Exp. Pharmacol. Physiol. 28, 493-503.
15. Frade J. M. (2002) Interkinetic nuclear movement in the vertebrate neuroepithelium: encounters with an old acquaintance. Prog. Brain Res. 136, 67-71.
16. Fukuchi-Shimogori T. and Grove E. A. (2001) Neocortex patterning by the secreted signaling molecule FGF8. Science 294, 1071-1074.
17. Fukuchi-Shimogori T. and Grove E. A. (2003) Emx2 patterns the neocortex by regulating FGF positional signaling. Nat. Neurosci. 6, 825-831.
18. Garel S., Huffman K. J. and Rubenstein J. L. (2003) Molecular regionalization of the neocortex is disrupted in Fgf8 hypomorphic mutants. Development 130, 1903-1914.
19. Gonzalez A. M., Buscaglia M., Ong M. and Baird A. (1990) Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues. J. Cell Biol. 110, 753-765.
20. Grove E. A. and Fukuchi-Shimogori T. (2003) Generating the cerebral cortical area map. Annu. Rev. Neurosci. 26, 355-380.
21. Guy G. R., Wong E. S., Yusoff P., Chandramouli S., Lo T. L., Lim J. and Fong C. W. (2003) Sprouty: how does the branch manager work? J. Cell Sci. 116, 3061-3068.
22. Hall A. B., Jura N., DaSilva J., Jang Y. J., Gong D. and Bar-Sagi D. (2003) hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl. Curr. Biol. 13, 308-314.
23. Hanafusa H., Torii S., Yasunaga T. and Nishida E. (2002) Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat. Cell Biol. 4, 850-858.
24. Hebert J. M., Lin M., Partanen J., Rossant J. and McConnell S. K. (2003) FGF signaling through FGFR1 is required for olfactory bulb morphogenesis. Development 130, 1101-1111.
25. Hevner R. F. (2005) The cerebral cortex malformation in thanatophoric dysplasia: neuropathology and pathogenesis. Acta Neuropathol. (Berl) 110, 208-221.
26. Inglis-Broadgate S. L., Thomson R. E., Pellicano F., Tartaglia M. A., Pontikis C. C., Cooper J. D. and Iwata T. (2005) FGFR3 regulates brain size by controlling progenitor cell proliferation and apoptosis during embryonic development. Dev. Biol. 279, 73-85.
27. Iwata T., Chen L., Li C., Ovchinnikov D. A., Behringer R. R., Francomano C. A. and Deng C. X. (2000) A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum. Mol. Genet. 9, 1603-1613.
28. Iwata T., Li C. L., Deng C. X. and Francomano C. A. (2001) Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice. Hum. Mol. Genet. 10, 1255-1264.
29. Jacobowitz D. M. and Abbott L. C. (1997) Chemoarchitedtonic Atlas of the Developing Mouse Brain. pp. 30-77. CRC Press, Florida, USA.
30. Kim H. J. and Bar-Sagi D. (2004) Modulation of signalling by Sprouty: a developing story. Nat. Rev. Mol. Cell Biol. 5, 441-450.
31. Lewis T. S., Shapiro P. S. and Ahn N. G. (1998) Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74, 49-139.
32. Li X., Wheldon L. and Heath J. K. (2003) Sprouty: a controversial role in receptor tyrosine kinase signalling pathways. Biochem. Soc. Trans. 31, 1445-1446.
33. Lin W., Furthauer M., Thisse B., Thisse C., Jing N. and Ang S. L. (2002) Cloning of the mouse Sef gene and comparative analysis of its expression with Fgf8 and Spry2 during embryogenesis. Mech. Dev. 113, 163-168.
34. Lovicu F. J. and McAvoy J. W. (2001) FGF-induced lens cell proliferation and differentiation is dependent on MAPK (ERK1/2) signalling. Development 128, 5075-5084.
35. Mallamaci A., Muzio L., Chan C. H., Parnavelas J. and Boncinelli E. (2000) Area identity shifts in the early cerebral cortex of Emx2-/-mutant mice. Nat. Neurosci. 3, 679-686.
36. Mason J. M., Morrison D. J., Basson M. A. and Licht J. D. (2006) Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol. 16, 45-54.
37. Minowada G., Jarvis L. A., Chi C. L., Neubuser A., Sun X., Hacohen N., Krasnow M. A. and Martin G. R. (1999) Vertebrate Sprouty genes are induced by FGF signaling and can cause chondrodysplasia when overexpressed. Development 126, 4465-4475.
38. Monuki E. S. and Walsh C. A. (2001) Mechanisms of cerebral cortical patterning in mice and humans. Nat. Neurosci. 4(Suppl.), 1199-1206.
39. Muzio L., DiBenedetto B., Stoykova A., Boncinelli E., Gruss P. and Mallamaci A. (2002) Emx2 and Pax6 control regionalization of the pre-neuronogenic cortical primordium. Cereb. Cortex 12, 129-139.
40. Naski M. C., Wang Q., Xu J. and Ornitz D. M. (1996) Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat. Genet. 13, 233-237.
41. Noh D. Y., Shin S. H. and Rhee S. G. (1995) Phosphoinositide-specific phospholipase C and mitogenic signaling. Biochim. Biophys. Acta 1242, 99-113.
42. Oh L. Y., Denninger A., Colvin J. S., Vyas A., Tole S., Ornitz D. M. and Bansal R. (2003) Fibroblast growth factor receptor 3 signaling regulates the onset of oligodendrocyte terminal differentiation. J. Neurosci. 23, 883-894.
43. Ohkubo Y., Uchida A. O., Shin D., Partanen J. and Vaccarino F. M. (2004) Fibroblast growth factor receptor 1 is required for the proliferation of hippocampal progenitor cells and for hippocampal growth in mouse. J. Neurosci. 24, 6057-6069.
44. Orr-Urtreger A., Givol D., Yayon A., Yarden Y. and Lonai P. (1991) Developmental expression of two murine fibroblast growth factor receptors, flg and bek. Development 113, 1419-1434.
45. Peters K., Ornitz D., Werner S. and Williams L. (1993) Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev. Biol. 155, 423-430.
46. Pirvola U., Ylikoski J., Trokovic R., Hebert J. M., McConnell S. K. and Partanen J. (2002) FGFR1 is required for the development of the auditory sensory epithelium. Neuron 35, 671-680.
47. Powers C. J., McLeskey S. W. and Wellstein A. (2000) Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer 7, 165-197.
48. Pringle N. P., Yu W. P., Howell M., Colvin J. S., Ornitz D. M. and Richardson W. D. (2003) Fgfr3 expression by astrocytes and their precursors: evidence that astrocytes and oligodendrocytes originate in distinct neuroepithelial domains. Development 130, 93-102.
49. Raballo R., Rhee J., Lyn-Cook R., Leckman J. F., Schwartz M. L. and Vaccarino F. M. (2000) Basic fibroblast growth factor (Fgf2) is necessary for cell proliferation and neurogenesis in the developing cerebral cortex. J. Neurosci. 20, 5012-5023.
50. Reuss B. and von Bohlen und Halbach O. (2003) Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res. 313, 139-157.
51. Rubin C., Litvak V., Medvedovsky H., Zwang Y., Lev S. and Yarden Y. (2003) Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops. Curr. Biol. 13, 297-307.
52. Sapieha P. S., Hauswirth W. W. and Di Polo A. (2006) Extracellular signal-regulated kinases 1/2 are required for adult retinal ganglion cell axon regeneration induced by fibroblast growth factor-2. J. Neurosci. Res. 83, 985-995.
53. Schlessinger J. (2000) Cell signaling by receptor tyrosine kinases. Cell 103, 211-225.
54. Shim K., Minowada G., Coling D. E. and Martin G. R. (2005) Sprouty2, a mouse deafness gene, regulates cell fate decisions in the auditory sensory epithelium by antagonizing FGF signaling. Dev. Cell 8, 553-564.
55. Shin D. M., Korada S., Raballo R., Shashikant C. S., Simeone A., Taylor J. R. and Vaccarino F. (2004) Loss of glutamatergic pyramidal neurons in frontal and temporal cortex resulting from attenuation of FGFR1 signaling is associated with spontaneous hyperactivity in mice. J. Neurosci. 24, 2247-2258.
56. Szebenyi G. and Fallon J. F. (1999) Fibroblast growth factors as multifunctional signaling factors. Int, Rev. Cytol. 185, 45-106.
57. Takahashi T., Nowakowski R. S. and Caviness V. S. Jr (1995) The cell cycle of the pseudostratified ventricular epithelium of the embryonic murine cerebral wall. J. Neurosci. 15, 6046-6057.
58. Tavormina P. L., Bellus G. A., Webster M. K. et al. (1999) A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene. Am. J. Hum. Genet. 64, 722-731.
59. Tole S., Gutin G., Bhatnagar L., Remedios R. and Hebert J. M. (2006) Development of midline cell types and commissural axon tracts requires Fgfr1 in the cerebrum. Dev. Biol. 289, 141-151.
60. Trokovic R., Trokovic N., Hernesniemi S., Pirvola U., Vogt Weisenhorn D. M., Rossant J., McMahon A. P., Wurst W. and Partanen J. (2003) FGFR1 is independently required in both developing midand hindbrain for sustained response to isthmic signals. EMBO J. 22, 1811-1823.
61. Tsang M. and Dawid I. B. (2004) Promotion and attenuation of FGF signaling through the Ras-MAPK pathway. Sci. STKE 2004, pe17.
62. Vaccarino F. M., Schwartz M. L., Raballo R., Nilsen J., Rhee J., Zhou M., Doetschman T., Coffin J. D., Wyland J. J. and Hung Y. T. (1999) Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis. Nat. Neurosci. 2, 246-253.
63. Webster M. K. and Donoghue D. J. (1996) Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 15, 520-527.
64. Zhou C., Tsai S. Y. and Tsai M. J. (2001) COUP-TFI: an intrinsic factor for early regionalization of the neocortex. Genes Dev. 15, 2054-2059.